Results
eNauka >
Results >
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
| Title: | Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study | Authors  : | Bar-Or, Amit; ...; Drulović, Jelena  ; ...; (broj koautora 19) |
Issue Date: | 2025 | Publication: | Lancet. Neurology | ISSN: | 1474-4422 Lancet Neurology Search Idenfier |
Publisher: | London, UK ; New York, NY : Lancet Pub. Group | Type: | Article | Collation: | vol. 24 br. 8 str. 656-666 | DOI: | 10.1016/S1474-4422(25)00174-7 | WoS-ID: | 001536709600001 | Scopus-ID: | 2-s2.0-105010741329 | PMID: | 40683275 | URI: | https://enauka.gov.rs/handle/123456789/995134 | URL: | https://www.sciencedirect.com/science/article/pii/S1474442225001747?via%3Dihub | Project: | F. Hoffmann-La Roche | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.